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Alterations in appetitive processing are central to the major psychological theories of addiction, with differential
predictions made by the reward deﬁciency, incentive salience, and impulsivity hypotheses. Functional MRI has
become the chief means of testing these predictions, with experiments reliably highlighting disturbances
at the level of the striatum, medial prefrontal cortex, and afﬁliated regions. However, demonstrations of
hypo-reactivity and hyper-reactivity of this circuitry in drug addicted groups are reported in approximately
equal measure. Similar ﬁndings are echoed in the emergent neuroimaging literature on pathological gambling,
which has recentlywitnessed a coming of age. The ﬁrst aim of this article is to consider some of themethodolog-
ical aspects of these experiments that could inﬂuence the observed direction of group-level effects, including the
baseline condition, trial structure and timing, and the nature of the appetitive cues (drug-related, monetary, or
primary rewards). The second aim is to highlight the conceptual traction that is offered by pathological gambling,
as amodel of a ‘toxicity free’ addiction and an illnesswhere tasks ofmonetary reinforcement afford amore direct
mapping to the abused commodity. Our conclusion is that relatively subtle decisions in task design appear capa-
ble of driving group differences in fronto-striatal circuitry in entirely opposing directions, even with tasks and
task variants that look ostensibly similar. Differentiation between the psychological theories of addiction will re-
quire a greater breadth of experimental designs, withmore research needed on processing of primary appetitive
cues, aversive processing, and in vulnerable/at-risk groups.
© 2013 The Authors. Published by Elsevier Inc.
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1. Introduction
Current conceptualisations of drug addiction are heavily informed
by the neurobiological basis of motivated behaviour, with a focus
primarily on appetitive processing. Several psychological theories
have been put forward to characterise the changes in appetitive
processing that either predispose the addicted state, or describe the
transition into drug addiction. For example, the reward deﬁciency
hypothesis (Blum et al., 2012; Comings and Blum, 2000) proposes
that a trait-related insensitivity to naturally-occurring reinforcement
predisposes the individual to drug taking as a means of compensation.
Incentive salience or sensitisation accounts (Robinson and Berridge,
1993, 2008) propose that the brain response to drugs of abuse becomes
potentiated over repeated use, so that drug seeking comes to dominate
goal-directed behaviour over healthy rewarded behaviours. Over the
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past decade, functional MRI (fMRI) studies of addicted populations
have become the central means of arbitrating between these ac-
counts, as brain reward systems can be assayed effectively with a
number of popular activation probes, such as Knutson's Monetary In-
centive Delay Task (MIDT) (Knutson et al., 2001). In one sense, these
experiments demonstrate remarkable consistency, in that they
reliably localise the dysregulation in addiction to dopamine-
innervated regions in the striatum and medial sector of the prefrontal
cortex (mPFC). However, the direction of effect is conspicuously incon-
sistent, with multiple, high-quality experiments indicating either
hypo-activity or hyper-activity of the same reward regions (Hommer
et al., 2011). The ﬁrst aim of the current article is to consider some
of the design features of these experiments that may determine the
observed direction of effect.
The second aim is to consider the broader category of addictive
disorders that will be recognised within the DSM5, which is speciﬁcally
proposed to include pathological gambling (to be renamed ‘Disordered
Gambling’) as the prototypical form of behavioural addiction. The ﬁrst
neuroimaging studies of pathological gambling were published in the
mid 2000s (Potenza et al., 2003a, 2003b; Reuter et al., 2005), and over
the past year, this ﬁeld has matured with the reporting of arguably
the four strongest fMRI studies to date (Balodis et al., 2012a; Miedl et
al., 2012; Sescousse et al., 2010; van Holst et al., 2012b). As with the
studies of drug addiction, these papers in pathological gambling have
isolated striatum andmPFC regions as lying at the core of this disrupted
network, but again, the direction of effects across the four studies is in-
consistent. In considering these ﬁndings, we will highlight the features
of pathological gambling thatwe believemake it a valuable experimen-
tal model for the addictions ﬁeld, and the leverage thatmay be afforded
by this illness for resolving the nature of the dysregulation in reinforce-
ment processing in drug addiction.
2. Psychological theories of drug addiction
Motivational circuits were originally implicated in addiction by
the observation that drugs of abuse increase dopamine transmission
within these circuits (Wise, 2004). The primary focus of these theo-
ries has been on the appetitive processing that governs behavioural
approach, and the inhibitory control of these approach behaviours
(Bechara, 2005; Goldstein and Volkow, 2002; Jentsch and Taylor,
1999). Within this framework, addiction may be related to either an
increase in approach behaviour to drug-related stimuli, or a decrease
in inhibitory control. While modern conceptualisations acknowledge
both processes, the alternative accounts vary in the weight they
afford to each. In addition, the accounts differentially emphasise either
the vulnerability factors that characterise the (premorbid) disposition
to addiction, or the transitional processes from casual consumption
into full-blown addiction. Critically, the theories described below
make different predictions about whether addicted individuals would
show an increased, normal, or decreased neural response to either
addiction-related stimuli, or non-drug-related appetitive cues. Such
predictions are highly amenable for testing with fMRI.
The reward deﬁciency hypothesis predicts that the susceptibility to
addiction stems from an insensitive or ineffective dopaminergic system
(Comings and Blum, 2000). In this state, natural rewards will yield only
an attenuated response, such that a rewarding stimulus will not drive
the dopaminergic system to the required threshold to trigger the brain's
‘reward cascade’ (Blum et al., 2012), and normal experienceswould not
adequately impact uponmotivated behaviour. As a result, the individu-
al would seek stronger experiences – including but by nomeans limited
to drug taking – to drive dopamine release and activate the reward
cascade. The reward deﬁciency hypothesis originated from genetic
data showing that a variant in the dopamine D2 receptor gene (Taq1A
DRD2) was more prevalent in patients with alcohol dependence
(Blum et al., 1990; Noble et al., 1991) and was associated with a
hypo-dopaminergic state. This genotype was subsequently linked to
other addictive disorders, including pathological gambling (Comings
et al., 1996, 2001). The critical hypo-dopaminergic state may also
occur via environmental routes such as prolonged exposure to stress
(Blum et al., 2012; Madrid et al., 2001). In humans, positron emission
tomography (PET) studies have demonstrated that the dopaminergic
release elicited by methylphenidate is lower in addicted individuals,
compared to controls (Martinez et al., 2007; Volkow et al., 1997).
However, while these results suggest a hypo-dopaminergic state in the
addicted brain, causality cannot be established. The hypo-dopaminergic
state may represent a pre-morbid vulnerability, or could be a conse-
quence of chronic drug use.
A contrasting model, incentive salience, also focuses on dopaminer-
gic signalling of approach behaviour (Robinson and Berridge, 1993,
2001, 2008), but it predicts that the addicted brain exists in a hyper-
dopaminergic state. Exogenous stimulation of the dopamine system is
known to cause an increase in dopaminergic activity that is resistant
to habituation, unlike the response to natural rewards (Di Chiara,
1999). Through repeated administration the dopaminergic response
becomes sensitised (Robinson and Becker, 1986). In addition, repeated
pairing of the drug (triggering a large dopaminergic response) with as-
sociated environmental stimuli (e.g., drug paraphernalia), leads these
stimuli to acquire increased salience and capture attention, over and
above naturally rewarding stimuli (Robinson and Berridge, 1993).
Unlike the reward deﬁciency hypothesis, there is no requirement for a
pre-morbid abnormality in the processing of natural rewards, as the
addiction develops as a consequence of exogenously-driven dopamine
release. Animal models have provided much support for this model
(e.g., Di Ciano, 2008; Harmer and Phillips, 1998; Taylor and Horger,
1999); for example, rats pre-exposed to cocaine showed facilitated
learningwhen associating a novel stimuluswith a conditioned reinforc-
er that was previously paired with cocaine (Di Ciano, 2008). However,
direct evidence in humans has been less compelling. For example, PET
studies indicate a reduction in striatal dopamine receptors in addicted
individuals (Martinez et al., 2004; Volkow et al., 1990), implying a
hypo-sensitive dopamine system. Robinson and Berridge (2008) postu-
late that sensitisation may only be expressed within certain psycholog-
ical contexts, like the environment of habitual drug taking rather than
a novel environment like a brain scanner, rendering the hypothesis
difﬁcult to test with functional neuroimaging.
The third class of model emphasises a deﬁciency in the top-down
inhibitory control of drug-taking,with a shift in the underlying neuroan-
atomical focus from the striatum to the PFC (Bechara, 2005). Trait eleva-
tions in impulsivity and their neuropsychological counterpart, poor
inhibitory control, may predispose initial drug experimentation as well
as transitions to abuse and dependence (Verdejo-García et al., 2008).
Similarly, it has been suggested that adolescencemay represent a critical
period of maturation, during which time increased levels of trait impul-
sivity leave an individual vulnerable to the development of an addiction
(Chambers et al., 2003). The impulsivity hypothesis gives no particular
weight to drug-related reinforcement, and thus similar changes would
be expected in addiction in the processing of natural rewards. In addi-
tion, by emphasising the top-down control of responding, the impulsiv-
ity hypothesis can readily accommodate the possibility that addiction
may be associated with a reduced sensitivity to aversive consequences,
either instead of or in addition to, any alteration in appetitive processing.
ThemPFC has been shown to be critical tomaintain successful inhibition
in animalmodels, as lesions of this region result in increased impulsivity
(Gill et al., 2010). In humans, a structural MRI study in healthy partici-
pants reported that mPFC volume in the human was correlated with
measures of impulsivity (Cho et al., 2012). The impaired response inhi-
bition and salience attribution (I-RISA) model of addiction (Goldstein
and Volkow, 2002; Goldstein et al., 2009) was developed to integrate
the increased salience of drug-related cues as a result of repeated drug
consumption (in line with the incentive salience model), and pre-
morbid deﬁciencies in impulsivity and top-down down control that
leave an individual susceptible to addiction.
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The three groups of models make differential predictions about
the neural basis of addiction, and speciﬁcally about increases or de-
creases in reward-related activity in addicted groups relative to con-
trols. In terms of subcortical dopaminergic activity, the reward
deﬁciency hypothesis proposes a reduction in reward-related process-
ing, which would affect drug-related and non-drug-related appetitive
processing similarly. The incentive salience and impulsivity hypothe-
ses both predict that the subcortical dopaminergic response to
drug-related stimuli is increased; however, these two accounts differ
in their predictions about the response to non-drug-related appeti-
tive stimuli: incentive salience is effectively agnostic on such stimuli,
whereas the impulsivity hypothesis predicts a generalised hypersen-
sitivity of the subcortical reward network. In addition, the impulsivity
hypothesis contains an important role for mPFC function, which
should be reduced and associated with the deﬁcient inhibitory con-
trol. The impulsivity hypothesis also best accommodates any changes
in the neural response to aversive events.
While several of these predictions are intuitively opposing, one
must bear in mind that addiction is a dynamic disorder with distinct
temporal stages. The distinct models may preferentially explain the
vulnerable state and disposition to drug initiation (reward deﬁciency)
or the transition into compulsive drug-taking (incentive salience).
Once the addiction is instantiated, there is a further cyclical pattern,
from binge/intoxication to withdrawal and negative affect, to preoccu-
pation and anticipation (Koob and Le Moal, 1997). These stages will
likely affectmotivational systems differently; while the ‘high’ during in-
toxication is characterised by increased striatal dopamine transmission
(Volkow et al., 1996), and withdrawal is associated with hypo-activity
of the same pathways (Martinez et al., 2004, 2005; Volkow et al.,
1997). Hence, clinical heterogeneity and the timing of testing relative
to the last drug use may have a pronounced effect on reward-related
tasks. Some recent hybrid models have begun to integrate concepts
across different stages of addiction (Blum et al., 2012; Leyton, 2007).
The incentive salience hypothesis acknowledges that dispositional
weaknesses in executive function may explain why only a subset of in-
dividuals exposed to addictive drugs go on to develop an addiction
(Robinson and Berridge, 2008). The two-factor dopamine model by
Leyton (2007) proposes that motivational circuitry is hyperactive in re-
sponse to addiction-related cues, but that thismay lead to a devaluation
of non-drug-related appetitive cues over time, such that neural process-
ing of natural rewardsmay be intact in the premorbid state but reduced
in addicted groups.
3. Using fMRI to investigate the neural basis for addiction
The blood oxygen level dependent (BOLD) signal measured during
fMRI provides an indirect marker of neural activity deriving from
changes in cerebral blood ﬂow, which in turn reﬂect the increased
energy demands that result from neural activity. Given the focus on
the psychological theories of addiction on dopamine transmission,
it is important to recognise that the fMRI signal is several steps re-
moved from the dopaminergic neurons of the reward network, such
that inferences about changes in dopaminergic activity should be
made with extreme caution.
The dopamine pathways originate in the dopaminergic midbrain
nuclei, although these nuclei are difﬁcult to visualise with fMRI
(Düzel et al., 2009; Limbrick-Oldﬁeld et al., 2012), and most studies
focus instead on regions that receive inputs from the dopaminergic
midbrain: the dorsal and ventral striatum, and multiple sectors of
the prefrontal cortex. These regions are larger, less prone to physio-
logical noise, and BOLD signal is thought to correlate best with local
ﬁeld potentials that reﬂect dendritic inputs to the region and activity
of local interneurons (Logothetis, 2003). While changes in the func-
tional activity of this ‘reward circuitry’ has been interpreted as a mod-
ulation of the underlying dopaminergic inputs, a region like the
striatum receives many inputs and contains many neuromodulators
besides dopamine. When interpreting fMRI results in terms of hypo-
or hyper-activity, one must also be aware that fMRI is unable to dis-
criminate between excitatory and inhibitory neural activity, and
thus a region could be ‘hyperactive’ as a result of a net increase in in-
hibitory activity.
Fortunately, we are not interpreting fMRI results in isolation. A
seminal multi-modal imaging study correlated PET measures of dopa-
mine release to a rewarded task against event-related fMRI responses
during reward anticipation in the same participants (Schott et al.,
2008). Dopamine release in the ventral striatum predicted the magni-
tude of BOLD signal changes in both the dopaminergic midbrain and
the ventral striatum. Translational data from experimental animals
also help substantiate the interpretations of imaging results; for
example by highlighting functional subdivisions in the striatum and
PFC that are at the boundary of the spatial resolution of fMRI.
This work associates the dorsal striatum primarily with the acquisi-
tion of response–reward associations (Balleine and O'Doherty, 2010;
see also O'Doherty et al., 2004) and habit formation (Haber and
Knutson, 2010; Yin and Knowlton, 2006) whereas the ventral stria-
tum is implicated in reward-related anticipation and prediction, and
response vigour (Balleine and O'Doherty, 2010; O'Doherty et al.,
2004; Roesch et al., 2009). Similar dissociations may be present in
PFC, with the medial orbitofrontal region and rostral portion of the
anterior cingulate implicated in stimulus value representations, con-
trasting with dorsal anterior cingulate holding action–value associa-
tions (Rushworth et al., 2011).
4. Neural processing of reward in drug addiction
Hommer et al. (2011) provide an authoritative and insightful
overview of neuroimaging data that bear on the reward deﬁciency
and impulsivity hypotheses, published up until 2010. Their conclu-
sion is that while PET evidence of reduced dopamine D2 availability
and blunted stimulant-induced dopamine release in drug addiction
strongly favours the reward deﬁciency hypothesis (Fehr et al.,
2008; Martinez et al., 2004; Volkow et al., 1997, 2001; Volkow et al.,
2007), the more numerous fMRI literature of reward processing com-
prises reports of increases and decreases in reward processing in sub-
stance use disorders in roughly equal measure. Recent papers have
continued this pattern of inconsistency. Common to many ﬁelds of re-
search in fMRI, a range of different tasks are used to investigate the neu-
ral basis of addiction. However, this cannot be the sole explanation of
the observed differences, as hypo-reactivity and hyper-reactivity
have been observed on ostensibly similar tasks. Consider two recent
studies with the monetary incentive delay task (MIDT), a simple and
standardised task developed to investigate reward-related processes
in the ventral striatum, with a particular focus on reward anticipation.
A study of adolescent smokers found a lower ventral striatal response
during reward anticipation, compared to non-smokers, and a negative
correlation with smoking frequency, in accord with the reward deﬁ-
ciency hypothesis (Peters et al., 2011). No group differences were
found during outcome processing. However, in the ﬁrst study to use
the MIDT in cocaine dependence, Jia et al. (2011) observed enhanced
bilateral ventral- and dorsal–striatal reactivity to both reward anticipa-
tion and reward outcome, and this hyper-reactivity predicted poorer
treatment outcomes (self-reported abstinence, urine toxicology) at
two-month follow-up. Even across studies in drug users with the
same preferred substance, the direction of effect is seen to fully reverse
across different studies; for example, in alcohol dependence (Beck et al.,
2009; Bjork et al., 2008; Wrase et al., 2007) or cannabis users (Nestor
et al., 2010; van Hell et al., 2010) (see Hommer et al., 2011 for full
descriptions of these studies).
Some of the inconsistencies in the ﬁeld are likely due to clinical or
demographic factors that act as moderators, such as the differences
between classes of drug (e.g., stimulants vs. opiates) (McNamara
et al., 2010), gender (Potenza et al., 2012), or treatment-seeking
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status (Stippekohl et al., 2012). Inclusion criteria are obviously impor-
tant; for example, the target group in the Peters et al.'s (2011) study
were adolescents who reported smoking at least one cigarette in the
last 30 days, while Jia et al. (2011) included cocaine users seeking
treatment for dependence. Thus, the similarities in task design must
be weighed against major differences in the stage and severity of ad-
diction. Even in studies of users preferring the same drug, there can
be dramatic differences in inclusion criteria. For example, in studies
of alcohol-dependence, Beck et al. (2009) and Wrase et al. (2007) ex-
cluded participants with a history of illicit drug use, while Bjork et al.
(2008) included illicit drug users. Length of abstinence is similarly
variable and known to impact on neural responses to drug-related
cues (David et al., 2007; Fryer et al., 2012).
Several variables in fMRI task design may also inﬂuence the direc-
tion of effects. Given the temporal properties of the BOLD signal, the
trial structure may be of even greater signiﬁcance than clinical
heterogeneity, and was favoured as one of the main explanations
for the inconsistent results reviewed by Hommer et al. (2011). Even
within a seemingly standardised task like the MIDT, one may be sur-
prised by the number of subtle variants that exist (see Fig. 1). Some
reports maximise power in the appetitive contrast by only comparing
rewarded cues against non-rewarded cues (Peters et al., 2011),
whereas others include a loss condition (Balodis et al., 2012a; Beck
et al., 2009; Bjork et al., 2011; Jia et al., 2011; Nestor et al., 2010;
Wrase et al., 2007). Studies in healthy volunteers have clearly
established the sensitivity of the striatal response to these contextual
factors (Bunzeck et al., 2010; Hardin et al., 2009; Nieuwenhuis et al.,
2005): for example, a zero-win outcome is processed differently in
tasks where loss can be sustained. The choice of baseline condition
will be a crucial determinant of whether group differences reﬂect
apparent increases or decreases in activity. Looking at the MIDT liter-
ature so far discussed, the baseline used is often a neutral cue or
outcome (Bjork et al., 2008; Jia et al., 2011; Peters et al., 2011;
Wrase et al., 2007), but some studies take alternative baselines like
the inter-trial interval (Nestor et al., 2010).
A more subtle issue exists in the trial structure of the task, in order
to de-couple various psychological phases within a trial. In a typical
appetitive task, four stages might occur (see Fig. 1): the presentation
of a motivational cue that creates a positive, neutral, or negative ex-
pectation on that trial, the participant's behavioural response to that
cue, an anticipatory stage (either a delay or a more interesting spin
of a wheel), and ﬁnally the delivery of the outcome. Without ade-
quate temporal separation of these phases (‘jitter’), group differences
that are detected at outcome could in fact be driven by abnormalities
bleeding across from the earlier phases, given the sluggish timecourse
of the BOLD signal. Thus, changes in deliberation or risk-taking during
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the response phase, or changes in anticipatory processing, could con-
found outcome effects. As is widely known from work in experimen-
tal animals, dopaminergic signalling is likely to shift over the course
of an appetitive task from the reward itself (i.e., the outcome phase)
to stimuli that predict those rewards (i.e., the cue or anticipation
phases). In the plethora of variants used in addictions research, the
overall task duration can be shortened considerably by removing
these jittered intervals and presenting at least some of the stages in
quick succession (Beck et al., 2009; Jia et al., 2011; Nestor et al., 2010;
Wrase et al., 2007). Conversely, other experiments have speciﬁcally
inserted jittered windows to isolate, for example, motor-preparatory
activity (known to recruit striatal regions) from reward anticipation
(Balodis et al., 2012a; Bjork et al., 2011; Peters et al., 2011), or reward
anticipation from reward outcome. Nevertheless, even taking this criti-
cal issue into account, in the studies that have jittered anticipation and
outcome we can still see variability of whether group differences occur
in anticipation (Beck et al., 2009; Peters et al., 2011; Wrase et al., 2007)
or at reward outcome (Balodis et al., 2012a; Jia et al., 2011).
Another methodological point concerns the nature of the reward
itself. The majority of studies of reward processing in drug addiction
have utilised monetary reinforcement (including all studies with the
MIDT). While the reasons for using monetary reinforcement across
experimental psychology is clear (e.g., clear motivational effects,
and the ability to model gains and losses within the same domain),
money is a complex reinforcer. First, its value is learned, albeit early
in life such that by adulthood the brain may regard money on a par
with primary rewards. Its subjective value differs between individuals
as a function of wealth (the ‘Bernoulli Effect’; see Tobler et al., 2007
for neural instantiation of this phenomenon), and is derived from its
capacity to be exchanged for other goods of value (i.e., it is fungible).
This creates a speciﬁc issue in studies of addiction, as money acquired
in an experimental setting can then be exchanged subsequently for
the drug of abuse, placing it at a somewhat ambiguous level of incen-
tive salience. It is unclear whether it should be regarded as an addic-
tion related cue, or a natural reward.
Given these difﬁculties with the use of monetary reinforcement in
studies of drug addiction, one useful design to gain leverage between
the competing psychological hypotheses is to employ non-ﬁnancial
(and non-drug-related) appetitive cues such as erotica or pleasant
tastes. These studies have generated a more uniform pattern of
hypo-reactivity in reward-related regions (Asensio et al., 2010;
Garavan et al., 2000; Wexler et al., 2001). For example, using erotic
images from the International Affective Picture Series in a relatively
large group of male cocaine dependent subjects, Asensio et al.
(2010) found a broadly similar network recruited by appetitive cues
in the two groups, but reduced activation in the dorsal and ventral
striatum and dorsomedial PFC in the cocaine group. These studies
support the reward deﬁciency hypothesis, but can also be accommo-
dated in variants of incentive salience (e.g., Leyton, 2007) that allow
the sensitisation of drug-related cues to drive an attenuation in the
response to natural reinforcers.
5. Pathological gambling
Since its inclusion in the DSM-III in 1980, pathological gambling
has been grouped in the impulse control disorders, alongside klepto-
mania, pyromania and trichotillomania. The DSM5 proposal to
re-classify it in the addictions category (Holden, 2010; Petry, 2010)
has been prompted by several lines of research, including empirical
evidence for a shared addiction vulnerability (e.g., Lind et al., 2012;
Lobo and Kennedy, 2009; Slutske et al., 2000) and substantial similar-
ities in the neural underpinning revealed primarily by fMRI (Leeman
and Potenza, 2012; Potenza, 2008). As well as being the ‘ﬂag-bearer’
for the behavioural addictions, we believe that pathological gambling
also provides an important model for the addictions ﬁeld more broad-
ly, for at least two reasons. The ﬁrst reason concerns the intractable
‘chicken and egg’ problem in addictions research (see Ersche et al.,
2010; Verdejo-García et al., 2008). The chronic consumption of most
drugs of abuse is associated with gross structural changes in the
brain, such that the neural signatures of premorbid vulnerability
cannot be dissociated from changes that have taken place as a conse-
quence of the drug use. Such overt neurotoxicity should be absent
in pathological gambling, and indeed two recent studies using
voxel-based morphometry were unable to detect signiﬁcant changes
in grey or white matter volumes in pathological gamblers (Joutsa
et al., 2011; van Holst et al., 2012a), contrasting with the dramatic
and widespread reductions in grey matter in a matched group with
alcohol dependence (Chanraud et al., 2007; van Holst et al., 2012a).
A further complication arising from the same effect is that group
comparisons of functional activity against healthy controls can be
confounded by structural volume differences, where such effects are
present in drug addictions. Admittedly, in pathological gamblers,
the regular cycle of winning and losing may conceivably engender
more subtle neuro-adaptive changes that might not be readily detect-
able with structural imaging protocols. Nevertheless, phenotypic
similarities between pathological gamblers and groups with drug
addictions, such as on trait impulsivity and neuropsychological
probes of risky decision-making, may be more aligned with vulnera-
bility mechanisms than the neurotoxic sequelae of chronic drug use.
The second kind of insight that may be afforded from research on
pathological gambling concerns that nature of reinforcement in neu-
roimaging studies. The experience of ﬁnancial wins, and instrumental
behaviour to obtain those outcomes, are the deﬁning features of gam-
bling, and key conditioning stages in the development of pathological
gambling (Blaszczynski and Nower, 2002). Thus, in research in indi-
viduals with pathological gambling, the abused ‘commodity’ is now
congruent with the experimental tractability of monetary reinforce-
ment in reward-based tasks. Unfortunately, the growing literature
that has used monetary tasks in pathological gamblers suffers from
the same heterogeneity that we have described above in drug addic-
tion. A groundbreaking early study from Reuter et al. (2005) used a
two-choice card guessing task to compare the brain response to
wins versus losses in pathological gamblers. Signal change in the ven-
tral striatum and ventral medial PFC (vmPFC) was reduced in the
pathological gamblers, and correlated negatively with gambling se-
verity. However, this study did not employ a neutral outcome condi-
tion, and only modelled outcome-related activity on each trial. The
baseline used was loss outcomes, hence any group differences could
be driven by either changes in loss- or gain-related processing. A
somewhat similar pattern was reported in the ventrolateral PFC
for feedback on a reversal learning task in pathological gamblers
(de Ruiter et al., 2009).
Inmore recent studies that tease apart the temporal dynamicswith-
in a trial, a more complicated pattern emerges. Van Holst et al. (2012b)
used a probabilistic choice game that varied both the magnitude and
probability of the potential reward across trials, and modelled brain
responses during the anticipation phase (see Fig. 1). Pathological gam-
blers displayed a greater response to the magnitude contrast (win 5
euros versus win 1 euro) in the dorsal striatum, compared to controls,
and the dorsal striatum and OFC also tracked gain-related expected
value to a greater extent in the pathological gamblers. However, in a
contemporaneous paper, Balodis et al. (2012a) reported a reduction in
fronto-striatal circuitry using the MIDT in pathological gamblers. Their
task enabled temporal separation of anticipation and outcome, and
during anticipation, the gamblers displayed reduced activity in ventral
striatumand vmPFC across all expectancy conditions (gains and losses).
On receipt of a ﬁnancial gain, the pathological gamblers also showed
decreased vmPFC activity.
The disparities between these two results are initially bafﬂing, but
there are some important design differences between the experiments
that may provide clues of wider relevance to the addictions ﬁeld. First,
while the tasks both employed monetary reinforcement, the precise
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form of presentation was very different (Leyton and Vezina, 2012): Van
Holst et al. (2012b) used realistic playing cards and images of actual
money (see Fig. 1), whereas Balodis et al. (2012a) did not involve a re-
alistic gambling scenario, and stated the amount to be won or lost in
simple text format. A pathological gambler may conceivably experience
the ﬁrst task as evocative of real play, whereas the second task may not
be closely associated with the addictive behaviour despite the availabil-
ity of monetary reinforcement. Leyton and Vezina (2012) suggest that
the processes of incentive salience may be speciﬁc to just a narrow set
of stimuli that are intimately related to the addiction. There are also fur-
ther differences between the two tasks besides the cues, including trial
timings and analysis. VanHolst et al. (2012b) used a contrast of large re-
ward anticipation against small reward anticipation, while Balodis et al.
(2012a) used a categorical contrast with a neutral anticipation period as
a baseline. Clearly group differences in the processing of magnitude
changes during anticipation are distinct from group differences in pro-
cessing of the anticipation of a rewarding vs. neutral outcome.
Moreover, the group differences described by van Holst et al.
(2012b) and Balodis et al. (2012a) studies refer to distinct sectors of
the striatum. The enhanced dorsal striatal activity in the van Holst
study (2012b) could be interpreted as evidence that gamblers are in-
clined to form action–outcome associations during gambling, where-
as the hypo-responsiveness in the ventral striatum in the Balodis
et al.'s (2012a) study could indicate inﬂexibility to update reward
values (for discussion see Balodis et al., 2012b; van Holst et al.,
2012c). Hence, the role of separate striatal subdivisions may be criti-
cal in interpreting these results.
Other neuroimaging studies suggest that group differences between
pathological gamblers and controls may depend on speciﬁc task con-
ditions. An fMRI study of blackjack indicated enhanced inferior frontal
gyrus and thalamus activity in problem gamblers only during high-
risk trials; no group differences were observed during low-risk trials
(Miedl et al., 2010). These results were corroborated with EEG, where
problem gamblers showed a positive amplitude over frontal cortex on
high-risk rewarded trials, whereas no group differences were seen on
low-risk trials (Hewig et al., 2010; Oberg et al., 2011). These results
are in line with the suggestion by Leyton and Vezina (2012), that the
processes of incentive salience in gamblers may become very speciﬁc
to a narrow set of high-risk opportunities.
The speciﬁc relevance of monetary reinforcement to pathological
gambling also allows a direct comparison of the ‘addictive’ reward
against natural rewards, such as food or sexual stimuli. This formed
the rationale behind a third recent experiment in pathological gam-
bling, comparing the neural response to ﬁnancial rewards and erotic
visual rewards, using an incentive delay task (Sescousse et al.,
2010). During anticipation, pathological gamblers showed a reduced
neural response in the ventral striatum for erotic rewards compared
to controls, consistent with the study in cocaine dependence de-
scribed above (Asensio et al., 2010). During anticipation, there was
no difference in the response to ﬁnancial rewards. However, during
the outcome phase, the neural response to ﬁnancial outcomes was
increased in the pathological gamblers compared to controls in the
orbitofrontal cortex. This pattern of results is not well accommodated
by any of the hypotheses for addiction outlined above, if taken on
their own. Rather, the data support a two process model, either
where the hyper-reactivity to addictive rewards drives an attenuation
of the response to natural rewards (Leyton, 2007) or where initial
reward deﬁciency is supplemented by an incentive salience process
to addiction-related cues (Blum et al., 2012). Note that either mecha-
nism assumes an incentive sensitisation process driven only by be-
haviour, with no exogenous dopamine input. A logical next step to
separate these possibilities would be to identify a high-risk group
for pathological gambling, such as ﬁrst-degree relatives, to fully
isolate the vulnerability markers.
The ﬁnal recent study in pathological gamblers has adopted a
computational approach to consider the neural representations of
reward as a function of changes in the delay to the reward (temporal
discounting) and the uncertainty of reward (probability discounting)
(Miedl et al., 2012). The underlying behavioural phenomena are
well-established: in problem gambling and drug addiction, there
is increased discounting of delayed rewards (i.e., a preference for im-
mediate reward) and a reduced discounting of uncertain rewards
(i.e., less risk aversion) (Madden et al., 2009). The Miedl et al.'s
(2012) experiment titrated the subjective value for both delayed
and probabilistic choices for each individual, and these values were
then reliably correlated with brain activity in the ventral striatum.
The pathological gamblers showed greater value representations in
ventral striatal in the temporal discounting task, but reduced value
representations during the probability discounting task, compared
to controls. These results implicate a distortion of the value functions
relating rewards to time and uncertainty in problem gamblers, and
these choice-based tasks converge on the same core pathophysiology
as revealed by the motivational tasks in the work above.
6. Conclusion
From the complex picture that has been described above, it is im-
portant to recognise the robust localisation of the group differences in
addiction to the reward-related circuitry comprising primarily the
ventral striatum and medial PFC. It is the inconsistent direction of
effects within this circuitry that forms the topic for discussion,
representing as it does a major obstacle in the use of fMRI data for
adjudicating between the psychological theories of addiction. One
view might be that the available data clearly highlight an impairment
in this system, and that the exact direction may be relatively
unimportant. However, our opinion from surveying this corpus of re-
search is that relatively subtle methodological decisions at the level of
the task design, trial structure, and analysis can have a critical impact
on the group differences observed. While these principles are well
recognised in imaging textbooks, we would encourage researchers
to be cognisant of the idea that such decisions may drive group differ-
ences in entirely opposing directions, and to consider these methodo-
logical inﬂuences before advocating support for an underlying theory.
Several factors are likely to be important in this regard: 1) inclusion of
positive, negative and neutral outcomes in the same task, or comparison
of only positive and neutral conditions. Neutral cues or outcomes
(which constitute the most standard baseline condition) are known to
be processed differently in these two contexts (e.g., Nieuwenhuis
et al., 2005); 2) the trial timings with regard to temporal segregation
of choice/response, anticipation, and outcome-related processing.
While it is tempting to prioritise shorter task lengths, and early work
in this area did often collapse across some phases, this is likely to ulti-
mately hinder consistency; and 3) the nature of the appetitive cues;
and evenwithin tasks using the same apparent cue type (e.g., monetary
outcomes), theremay be ameaningful inﬂuence of the graphical repre-
sentation, such as coin images versus text feedback of monetary
outcomes (see Fig. 1), which may be sufﬁcient to drive addiction-
related processing.
Given these design issues, on-going functional neuroimaging
research on drug addiction would beneﬁt from a broader range of
study designs. To best differentiate between the dominant psycholog-
ical models, three kinds of design are particularly powerful. It is high-
ly likely that drug-related cues are processed differently from other
non-addiction-relevant appetitive cues in addicted individuals, al-
though very few studies have directly compared these classes of cue
in the same design (see Sescousse et al., 2010 for an exception).
Given the complexities with the use of money as a fungible reinforcer
in drug addiction, a fruitful approach is tomeasure the neural responses
to primary rewards such as erotica or pleasant tastes (Asensio et al.,
2010; Garavan et al., 2000; Horder et al., 2010). Second, it is difﬁcult
to disentangle the dominant psychological theories in studies in drug
addicted groups, where the premorbid vulnerability factors (such as
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reward hyposensitivity) may have already been altered by the transi-
tional processes into addiction, including the neurotoxic and
neuroadaptive changes induced by chronic drug use. Research in
high-risk groups by virtue of family history, genotype, or personality
dispositions such as trait impulsivity, is required to isolate markers of
vulnerability per se, and research on pathological gambling may also
be useful in this regard. Third, with the historical emphasis on dopa-
mine focussing work on the appetitive system, far less neuroimaging
work has sought to quantify aversive processing in addiction. Neverthe-
less, a number of psychophysiological studies have described an atten-
uated response to aversive cues in addictions, including deﬁcits in
Pavlovian fear conditioning (Brunborg et al., 2010; McGlinchey-
Berroth et al., 1995, 2002), and the error-related negativity (Franken
et al., 2007). While preliminary fMRI work has corroborated a blunting
of loss-related activity in the striatum, anterior cingulate and insula in
drug addiction (de Ruiter et al., 2012; Forman et al., 2004; Kaufman et
al., 2003), these studies are yet to consider issues such as reinforcer
type and stage of processing (e.g., anticipation versus outcome) that
are raised in the far more numerous studies of appetitive processing.
Finally, we would emphasise the insights that are offered by re-
search on individuals with pathological gambling within the addic-
tions framework. Studies of pathological gamblers can reveal the
neural underpinnings of addiction in an illness that is not confounded
by the pronounced neurotoxic effects that result from substance
abuse; indeed recent VBM experiments in pathological gamblers
have detected no signiﬁcant structural differences (Joutsa et al.,
2011; van Holst et al., 2012a). In addition, we have highlighted
some of the complexities with using money as the reinforcer in stud-
ies of drug addiction; namely that it is a complex learned reinforcer
that is exchangeable (at least in principle) for the drug of abuse.
Given the practical utility of using monetary reinforcement in neuro-
imaging tasks, pathological gambling represents a condition where
there is direct convergence of the task reinforcer and addictive cue:
for pathological gamblers money is an addiction-related cue. The
fMRI literature on pathological gambling has matured in the past
two years, and while future work is likely to elaborate on important
clinical predictors like length of abstinence and treatment-seeking
status, which have received little consideration so far, signiﬁcant
progress has already been made. Importantly, abstinence is not re-
quired for the investigation of pathological gambling, due to the
lack of intoxication effects. Therefore, this could afford investigators
the opportunity to investigate all stages of the addiction cycle. As
pathological gambling is re-classiﬁed with the substance addictions
in the forthcoming DSM5, we anticipate further lines of convergence
from pathological gambling to drug addiction and vice versa.
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